News
AcroMetrix BCR-ABL External Molecular Panel: An Accurate Testing Method for Chronic Myeloid Leukemia
To support the validation and verification of new assays and to challenge the existing assays in oncology testing, Thermo Fisher Scientific launches Thermo Scientific Acrometrix BCR-ABL Panel. The ...
2d
Medical Device Network on MSNFlorida Cancer Specialists & Research Institute introduces liquid biopsy testFlorida Cancer Specialists & Research Institute (FCS) in the US has introduced liquid biopsy, a blood test that rapidly ...
Asuragen and Life Technologies obtained a CE-mark and have launched the BCR/ABL1 Quant™ Test in Europe. The in vitro diagnostic is intended to aid clinicians in the monitoring and treatment of ...
The presence of the BCR-ABL fusion protein in virtually all patients with CML and its required tyrosine kinase activity make CML ideal for testing a specific inhibitor of this enzyme. In our phase ...
The test detects the BCR-ABL T315I mutation in chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL) patients. The MolecularMD BCR-ABL T315I ...
It can save lives,” she says. Using metabolite-profiling methods, Matrix-Bio’s VeraMarker™-BCR blood test correctly predicted a recurrence of breast cancer an average of 13 months before ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results